Lung Cancer Trials Ask AI to find trials
Not Yet RecruitingNot applicableNCT07732686
Official study title

Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

Study summary

The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedProton Transfer Reaction Mass Spectrometry Analysis

The study team can explain what participation involves.

Who it may be forPancreas Cancer · Hepatocellular Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 29, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Not Yet Recruiting

The study is not accepting participants yet.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Oklahoma

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Oklahoma
Interventions being studied
Device: Proton Transfer Reaction Mass Spectrometry Analysis
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age ≥ 18 at the time of consent. Male and female patients to be tested.
  • Capable of understanding written and/or spoken English language.
  • Able to provide informed consent.
  • Cancer of any type.
  • Newly diagnosed cancer and untreated or established diagnosis of cancer. For established cancer patients, no active anti-cancer treatment for more than one month (reasons for no treatment are such as relapse, progression of cancer, refractory, or intolerance to treatment etc.)
Reasons someone may not be able to joinExclusion criteria
  • Under the age of 18.
  • Anticipated inability to complete breath sampling procedure.
  • Unable to provide informed consent.
  • Pregnant women
  • Active respiratory infection symptoms
  • Recent use of antibiotics
  • Difficulty in performing coached exhalation
  • Individuals who are unable to follow the instructions
  • Cancer patients who are on active treatment for cancer or have received cancer treatment within one month

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • OU Health Stephenson Cancer CenterOklahoma City, Oklahoma

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 29, 2026. Always confirm current availability with the study team.

View original record ↗